Ventyx biosciences announces appointment of matthew moore as chief operating officer

San diego, may 16, 2024 (globe newswire) -- ventyx biosciences, inc. (nasdaq: vtyx), (“ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a range of inflammatory diseases with significant unmet medical need, today announced the appointment of industry veteran matthew moore as chief operating officer.
VTYX Ratings Summary
VTYX Quant Ranking